Phathom Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-James N. Topper(17.4%),Patrick J. Heron(17.3%)等
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Henderson Molly
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Nabulsi Azmi
Phathom Pharmaceuticals | 4:持股變動聲明-董事 KARBE FRANK
Phathom Pharmaceuticals | 4:持股變動聲明-董事 Topper James N
Phathom Pharmaceuticals | 4:持股變動聲明-董事 Parikh Asit
Phathom Pharmaceuticals | 4:持股變動聲明-董事 COLA MICHAEL F
Phathom Pharmaceuticals | 4:持股變動聲明-董事 FIELDS HEIDI
Phathom Pharmaceuticals | 4:持股變動聲明-董事 KARBE FRANK
Phathom Pharmaceuticals | 4:持股變動聲明-董事 Stenhouse Mark
Phathom Pharmaceuticals | 4:持股變動聲明-董事 Socks David A
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Henderson Molly
Phathom Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(4.8%)
Phathom Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Takeda Pharmaceutical Company Limited(5.4%)
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Curran Terrie
Phathom Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Carlyle Group Inc.(6.1%),Carlyle Holdings I GP Inc.(6.1%)等
Phathom Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Invesco Ltd.(5.5%)
Phathom Pharmaceuticals | 3:首次持股聲明-股東 Medicxi Ventures Management (Jersey) Ltd
Phathom Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Medicxi Ventures Management (Jersey) Limited(13.0%),Medicxi Growth I GP Limited(6.6%)等
Phathom Pharmaceuticals | 4:持股變動聲明-股東 TAKEDA PHARMACEUTICAL CO LTD
暫無數據